Six RNAi-Related Patent Application s Published by the USPTO | GenomeWeb

Title: Compositions and Methods for Gene Silencing

Number: 20050229272

Filed: April 19, 2005 PCT Filed: Jan. 2, 2001

Lead Inventor: Monica Driscoll, Rutgers University

According to the patent application's abstract, "DNA constructs are provided for disrupting gene expression in targeted organisms."

Title: Method for Producing Non-Human Mammal RNAi Phenotype Using Papilloma Virus Vector

Number: 20050229266

Filed: Jan. 14, 2005

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.